9-98790302-G-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_173551.5(ANKS6):c.664C>G(p.Arg222Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000028 in 1,606,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R222Q) has been classified as Likely benign.
Frequency
Consequence
NM_173551.5 missense
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 16Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_173551.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKS6 | NM_173551.5 | MANE Select | c.664C>G | p.Arg222Gly | missense | Exon 2 of 15 | NP_775822.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKS6 | ENST00000353234.5 | TSL:1 MANE Select | c.664C>G | p.Arg222Gly | missense | Exon 2 of 15 | ENSP00000297837.6 | ||
| ANKS6 | ENST00000466120.1 | TSL:2 | n.195C>G | non_coding_transcript_exon | Exon 1 of 3 | ||||
| ANKS6 | ENST00000471846.1 | TSL:2 | n.712C>G | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000156 AC: 38AN: 244172 AF XY: 0.0000752 show subpopulations
GnomAD4 exome AF: 0.0000303 AC: 44AN: 1454428Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 722450 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Nephronophthisis 16 Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 222 of the ANKS6 protein (p.Arg222Gly). This variant is present in population databases (rs41283630, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ANKS6-related conditions. ClinVar contains an entry for this variant (Variation ID: 641730). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at